VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,000 | +100.0% | 70 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 70 | -74.1% | 0.00% | -100.0% |
| Q3 2017 | $4,000 | -20.0% | 270 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $5,000 | -37.5% | 270 | -62.8% | 0.00% | -33.3% |
| Q1 2017 | $8,000 | -27.3% | 725 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $11,000 | -15.4% | 725 | +38.1% | 0.00% | -33.3% |
| Q3 2016 | $13,000 | +18.2% | 525 | 0.0% | 0.01% | +20.0% |
| Q2 2016 | $11,000 | -21.4% | 525 | 0.0% | 0.01% | -28.6% |
| Q1 2016 | $14,000 | -73.6% | 525 | 0.0% | 0.01% | -74.1% |
| Q4 2015 | $53,000 | -43.6% | 525 | 0.0% | 0.03% | -47.1% |
| Q3 2015 | $94,000 | -19.7% | 525 | 0.0% | 0.05% | -15.0% |
| Q2 2015 | $117,000 | +12.5% | 525 | 0.0% | 0.06% | +13.2% |
| Q1 2015 | $104,000 | +38.7% | 525 | 0.0% | 0.05% | +35.9% |
| Q4 2014 | $75,000 | – | 525 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |